• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤患者化疗后外周血干细胞采集中恶性B细胞的检测

Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma.

作者信息

Dreyfus F, Ribrag V, Leblond V, Ravaud P, Melle J, Quarre M C, Pillier C, Boccaccio C, Varet B

机构信息

Department of Haematology and Blood Bank, Hôpital Cochin, Paris.

出版信息

Bone Marrow Transplant. 1995 May;15(5):707-11.

PMID:7670399
Abstract

Autologous transplantation after high-dose chemo or radiotherapy is now frequently used for the treatment of patients with multiple myeloma (MM). The collection of peripheral blood stem cells (PBSC) has a theoretical advantage over autologous bone marrow collection as the malignant plasmacytic contamination is believed to be lower. However, the extent of B cell contamination in PBSC has not been extensively investigated. Using an immunoglobulin heavy chain gene 'fingerprinting' technique at diagnosis and during apheresis after one cycle of chemotherapy we detected a monoclonal population in 44% of PBSC samples (9 positives in 22 studied). There was no correlation between contamination and sex, age, Durie and Salmon classification, C-reactive protein and albumin. A significant correlation was observed with beta 2 microglobulin serum level (P = 0.02). Twenty one patients were grafted and up to the present, with a mean follow-up of 12 months, 6 patients have relapsed including 4 patients with contaminating B cells. Our results suggest that PBSC contamination, defines a 'poor risk' group of patients, with poor prognosis. However, we could not exclude reinitiation of the disease by plasmacyte stem cells after grafting.

摘要

高剂量化疗或放疗后的自体移植目前常用于治疗多发性骨髓瘤(MM)患者。外周血干细胞(PBSC)采集相对于自体骨髓采集具有理论优势,因为据信恶性浆细胞污染较低。然而,PBSC中B细胞污染的程度尚未得到广泛研究。在诊断时以及化疗一个周期后的单采过程中,使用免疫球蛋白重链基因“指纹识别”技术,我们在44%的PBSC样本中检测到单克隆群体(22个研究样本中有9个阳性)。污染与性别、年龄、Durie和Salmon分期、C反应蛋白及白蛋白之间无相关性。观察到与β2微球蛋白血清水平存在显著相关性(P = 0.02)。21例患者接受了移植,截至目前,平均随访12个月,6例患者复发,其中4例患者的B细胞存在污染。我们的结果表明,PBSC污染定义了一组“高危”患者,预后较差。然而,我们不能排除移植后浆细胞干细胞引发疾病复发的可能性。

相似文献

1
Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma.多发性骨髓瘤患者化疗后外周血干细胞采集中恶性B细胞的检测
Bone Marrow Transplant. 1995 May;15(5):707-11.
2
Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.对VDJH扩增片段进行基因扫描是一种具有临床相关性的技术,用于检测接受自体外周血干细胞移植的多发性骨髓瘤患者单采血液成分制品中污染的肿瘤细胞。
Bone Marrow Transplant. 2001 Oct;28(7):665-72. doi: 10.1038/sj.bmt.1703219.
3
Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy.接受大剂量治疗的多发性骨髓瘤患者外周血干细胞移植中的骨髓瘤细胞污染
Bone Marrow Transplant. 1994 Jul;14(1):47-50.
4
High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome.多发性骨髓瘤的大剂量疗法:CD34+外周血干细胞阳性选择对血液学植入和临床结局的影响。
Haematologica. 2000 Mar;85(3):269-74.
5
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.异常细胞遗传学预示着多发性骨髓瘤患者在接受大剂量治疗和自体血细胞移植后的生存率较低。
Bone Marrow Transplant. 1999 Sep;24(5):497-503. doi: 10.1038/sj.bmt.1701943.
6
Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation.多发性骨髓瘤患者在高剂量治疗联合外周血干细胞移植过程中循环肿瘤细胞的分析
Bone Marrow Transplant. 1999 May;23(10):1019-27. doi: 10.1038/sj.bmt.1701767.
7
Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34+ stem cells.造血CD34+干细胞自体移植后,通过扩增多发性骨髓瘤患者的CDR-III IgH区域进行临床和分子随访。
Haematologica. 1999 May;84(5):397-404.
8
High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.大剂量化疗后自体造血干细胞移植治疗多发性骨髓瘤
Natl Med J India. 2003 Jan-Feb;16(1):16-21.
9
CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma.在多发性骨髓瘤患者接受多轮高剂量治疗及动员后,采用CD34+选择法获取自体外周血干细胞用于移植。
Bone Marrow Transplant. 2000 Jun;25(11):1175-84. doi: 10.1038/sj.bmt.1702408.
10
IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation.IgD型多发性骨髓瘤——化疗及自体干细胞移植后的临床特征与预后
Ann Hematol. 2005 Feb;84(2):115-7. doi: 10.1007/s00277-004-0944-x. Epub 2004 Oct 22.

引用本文的文献

1
Is Quantification of Measurable Clonal Plasma Cells in Stem Cell Grafts (gMRD) Clinically Meaningful?干细胞移植中可测量的克隆性浆细胞定量(gMRD)具有临床意义吗?
Front Oncol. 2022 Feb 23;12:800711. doi: 10.3389/fonc.2022.800711. eCollection 2022.
2
Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma.基质细胞衍生因子-1α/趋化因子受体4轴在多发性骨髓瘤中的作用及治疗靶向
Cancers (Basel). 2021 Apr 9;13(8):1793. doi: 10.3390/cancers13081793.
3
Detection of minimal residual disease in multiple myeloma and acute leukaemia.多发性骨髓瘤和急性白血病微小残留病的检测
Med Oncol. 1996 Jun;13(2):121-31. doi: 10.1007/BF02993863.